0001567619-20-020717.txt : 20201207
0001567619-20-020717.hdr.sgml : 20201207
20201207180200
ACCESSION NUMBER: 0001567619-20-020717
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201203
FILED AS OF DATE: 20201207
DATE AS OF CHANGE: 20201207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kollins John A
CENTRAL INDEX KEY: 0001391070
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39041
FILM NUMBER: 201373740
MAIL ADDRESS:
STREET 1: SATSUMA PHARMACEUTICALS, INC.
STREET 2: 400 OYSTER POINT BOULEVARD, SUITE 221
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Satsuma Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001692830
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813039831
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 OYSTER POINT BOULEVARD
STREET 2: SUITE 221
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 64080
BUSINESS PHONE: 415-505-0809
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BOULEVARD
STREET 2: SUITE 221
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 64080
4
1
doc1.xml
FORM 4
X0306
4
2020-12-03
0
0001692830
Satsuma Pharmaceuticals, Inc.
STSA
0001391070
Kollins John A
C/O SATSUMA PHARMACEUTICALS, INC.
400 OYSTER POINT BOULEVARD, SUITE 221
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
President and CEO
Stock Option (Right to Buy)
4.60
2020-12-03
4
A
0
240000
0.00
A
2030-12-03
Common Stock
240000
240000
D
Twenty Five Percent (25%) of the shares subject to the option vest one year measured from December 3, 2020 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
/s/ Thomas P. O'Neil as Attorney in Fact for John A. Kollins
2020-12-07